Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study. - Robertson CA; Jacqmein J; Selmani A; Galarza K; Oster P (Human vaccines & immunotherapeutics, 2023)